Research Topic: disease biomarkers

Role of Candida species in pathogenesis, immune regulation, and prognostic tools for managing ulcerative colitis and Crohn’s disease

mycolabadmin

This article explores how fungi, particularly Candida species, contribute to inflammatory bowel diseases like Crohn’s disease and ulcerative colitis. The fungal microbiota becomes imbalanced in IBD patients, triggering harmful immune responses and worsening inflammation. The researchers propose that measuring specific Candida levels could help doctors diagnose disease severity and predict treatment response, opening new possibilities for personalized IBD management.

Read More »

Characterization of the gut mycobiome in patients with non-alcoholic fatty liver disease and correlations with serum metabolome

mycolabadmin

This research reveals that the types of fungi living in our gut are linked to fatty liver disease in ways we didn’t fully understand before. While researchers have long studied bacteria in our gut, they largely ignored fungi, which turns out to play an important role too. The study found that certain fungal species are more common in people with fatty liver disease, and these fungi influence the metabolites (chemical compounds) in the blood that affect liver health. By combining information about fungi, bacteria, and blood chemistry, scientists developed a test that could identify fatty liver disease with 77% accuracy, suggesting that looking at gut fungi could help doctors diagnose and treat this common liver condition.

Read More »
Scroll to Top